[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Prostate Cancer Partnering Landscape Discussed by CurrentPartnering

05 Mar 2012 • by Natalie Aster

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

New report “Prostate Cancer Partnering 2007-2012” by CurrentPartnering provides details of the latest prostate cancer deals announced in the life sciences.

The report provides an overview of prostate cancer partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors prostate cancer technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Report Details:

Prostate Cancer Partnering 2007-2012
Published: February, 2012
Pages: 200
Price: US$ 995,00

This report contains a comprehensive listing of all prostate cancer partnering deals announced since 2007 including financial terms where available including over prostate cancer links to online deal records of actual prostate cancer partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.

In addition, the report provides summary charts and tables that disclose trends in prostate cancer deal making as well as an overview of the distribution of payment terms as disclosed by the parties to the deals.

Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

More information can be found in the report “Prostate Cancer Partnering 2007-2012” by CurrentPartnering.

To order the report or ask for sample pages contact [email protected]


MarketPublishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]

Analytics & News

Weekly Digest